About this item

Six million people in the United States meet the criteria for fibromyalgia, which is a disorder characterized by a combination of pain, fatigue, and related symptoms. On average, these patients see about four doctors before they are correctly diagnosed, and many are convinced they have a life-threatening illness such as an advanced stage of cancer. About $600 billion is spent annually in the United States to diagnose or manage chronic pain, including litigation fees, and it is estimated that fibromyalgia patients run up $20 billion in medical expenses annually. Despite these alarming numbers, there is a lack of understanding and a dearth of reliable information about fibromyalgia for patients. This fully updated edition of Making Sense of Fibromyalgia distills complex concepts and symptoms into an easily understandable narrative.



About the Author

Daniel J. Wallace

Daniel Jeffrey Wallace is an American rheumatologist, clinical professor, author, and fellow. Wallace has published 400 peer reviewed publications, 8 textbooks, and 25 book chapters on topics such as lupus, Sjogren syndrome, osteoarthritis, and fibromyalgia. He has the largest cohort of lupus patients in the United States (2000) .A full professor of medicine (Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA) , he is associate director of the Rheumatology Fellowship Program at Cedars-Sinai. His seminal contributions to research include being an author of the first paper to demonstrate vitamin D dysfunction and the importance of interleukin 6 in lupus, conducting the first large studies of apheresis in rheumatoid arthritis and lupus, and insights into the mechanisms of action of antimalarials. Wallace's research accomplishments also include conducting many clinical rheumatic disease trials, examining the role of microvascular angina and accelerated atherogenesis in lupus, and work on anti-telomere antibodies which have garnered him 5 papers in . Wallace's monograph, , has sold over 100,000 copies since 1995.



Read Next Recommendation

Report incorrect product information.